Web Analytics

3 Latest Announced Rounds

  • $5,000,000
    Series A

    1 Investors

    Software Development
    Nov 20th, 2024
  • $32,000,000
    Unknown

    1 Investors

    Financial Services
    Nov 20th, 2024
  • $24,000,000
    Unknown
    IT System Custom Software Development
    Nov 20th, 2024
$2,096.39M Raised in 86 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Concept Matrix Solutions, Inc.

start up
United States - Newbury Park, CA
  • 09/11/2023
  • Unknown
  • $1,200,000

Concept Matrix Solutions brings your products to life! We are a technology-based formulation, development, and manufacturing company dedicated to creating novel and cutting-edge therapeutic consumer and medical products.

We formulate products using proprietary encapsulation techniques designed to increase bio-availability and stability, then deliver the active ingredients through patented drug delivery platforms such as;

● Oral Thin Film: shelf-stable and discreet oral dissolving film for increased and faster absorption,
● Oral Solutions: water-based formulas that stabilize both water and oil-soluble ingredients,
● Topicals: shelf-stable formulations that target the surface or penetrate beneath the skin.

These are used to develop edibles, drinkables, tinctures, skincare, powders, tablets, sprays, gummies, and more.

As our drug delivery systems evolve, it is CMS’s continuing strategy to push the envelope of what products are possible, while increasing productivity and manufacturing potential. Our team is dedicated to continued innovation and developing technologies that provide truly effective products with complex formulations and precision dosing.

Our projects are leading the industry in stabilizing compounds and increasing dosing loads to expand its many uses and help brands reach entirely new markets or consumer segments.


Related People

Tony LaRosaFounder

Tony LaRosa United States - Los Angeles County, California

Concept Matrix Solutions has been a leader in novel drug delivery development with cannabinoids for over 10 years. CMS introduced the first Oral Thin Film delivery of cannabinoid molecules in California in 2008.